Investor Alert

Cerecor Inc.



After Hours

 --Quotes are delayed by 20 min

Jul 23, 2021, 7:59 p.m.





+0.11 +3.86%


Volume 16,298

Quotes are delayed by 20 min


Previous close

$ 2.90

$ 2.85


-0.05 -1.72%

Day low

Day high




52 week low

52 week high




H. Jeffrey Wilkins

Dr. H. J. Wilkins, MD, is a Chief Medical Officer at Cerecor, Inc. Dr. Wilkins was previously employed as a Chief Medical Officer & Senior Vice President by Zyla Life Sciences, a Chief Medical Officer by Lycera Corp., a Partner by Velicept Therapeutics, Inc., a Chief Medical Officer & Head-Medical Affairs by Ceptaris Therapeutics, Inc., a Senior Vice President-Clinical Development by Ception Therapeutics, Inc., a Vice President-Clinical Pharmacology by GlaxoSmithKline Plc, a Chief Medical Officer by Onspira Therapeutics, Inc., and a Chief Executive Officer by Trivalley Primary Care PC. He received his undergraduate degree from Bucknell University and a doctorate degree from Temple University (Pennsylvania).


Date Shares Transaction Value
06/10/2021 912   Acquisition at $2.28 per share. 2,079

Officers and Executives

Mr. Michael F. Cola
Chairman & Chief Executive Officer
Mr. Schond L. Greenway
Chief Financial Officer & Treasurer
Dr. Garry Arthur Neil
Chief Scientific Officer
Dr. H. Jeffrey Wilkins
Chief Medical Officer
Dr. Younok Dumortier Shin
Chief Technology Officer
Dr. Lisa Hegg
Vice President-Research & Development Programs
Mr. James A. Harrell
Chief Commercial Officer
Mr. Joseph M. Miller
Mr. Christopher Sullivan
Chief Accounting Officer
Ms. Colleen Matkowski
Vice President-Global Regulatory Affairs
Dr. Suzanne Louise Bruhn
Lead Independent Director
Dr. Gilla Kaplan
Independent Director
Dr. Gunnar Magnus Modee Persson
Independent Director
Mr. Phillip P. Gutry
Independent Director
Mr. Steven Joseph Boyd
Independent Director
Link to MarketWatch's Slice.